San Diego Union-Tribune

First COVID, now HIV. Moderna and San Diego researchers race to make a vaccine

After developing a COVID-19 vaccine in record time, Moderna is teaming up with San Diego scientists to use the biotech’s technology to make shots against HIV, one of the world’s most complex and ...
Medscape

HIV Prophylaxis Following Non-occupational Exposure: Guideline and Commentary

If the source person's HIV screening test result is negative but there has been a risk for HIV exposure in the previous 6 weeks, plasma HIV RNA testing of the source person is also recommended. In ...
Medscape

Two-Drug HIV Regimen Matches Standard of Care Therapy in Absence of Drug Resistance Testing

Dolutegravir plus lamivudine demonstrates noninferiority to the standard-of-care three-drug regimen in treatment-naive patients with HIV without preliminary drug resistance testing. Researchers ...
Rolling Out

When your negative HIV test means you need another

Receiving a non-reactive HIV test result brings immense relief for most people, but understanding what this outcome truly means requires more than a simple celebration. While a negative result ...
FierceBiotech

Moderna, Excision each enter HIV battle with mRNA and CRISPR tech

Moderna and Excision BioTherapeutics are stepping into a battle with HIV, a 41-year epidemic that has confuddled drug developers and vaccine makers the world over. The COVID-19 vaccine maker has ...
Science Daily

Researchers develop digital test to directly measure HIV viral load

A milliliter of blood contains about 15 individual drops. For a person with human immunodeficiency virus (HIV), each drop of blood could contain anywhere from fewer than 20 copies of the virus to more ...
EurekAlert!

“Dormant” HIV produces RNA and proteins during anti-retroviral therapy

HIV anti-retroviral therapy is considered a treatment and not a cure because patients usually carry a reservoir of HIV-infected cells that can re-emerge if treatment stops. These reservoirs have long ...